Skip to content
Biogen
-
Biogen completes USD85M acquisition of Alcyone Therapeutics to advance CNS drug delivery technology
The acquisition centers on Alcyone’s innovative ThecaFlex DRx drug delivery system, an experimental implantable device that represents a significant advancement in treating neurological disorders.